Previous Page  2 / 20 Next Page
Information
Show Menu
Previous Page 2 / 20 Next Page
Page Background

Page 38

Notes:

conferenceseries

.com

Volume 8, Issue 6

J Neurol Neurosci

ISSN: 2171-6625 Neuro, an open access journal

Neuroscience 2017

October 16-17, 2017

OCTOBER 16-17, 2017 OSAKA, JAPAN

17

TH

Global Neuroscience Conference

Carvacrol protects against 6-OHDA toxicity in a PC12 inducible cell model for Parkinsonism

Mahboubeh Manouchehrabadi

1

, Torkaman-Boutorabi A

2

and Farhadi M

1

1

Islamic Azad University, Iran

2

Tehran University of Medical Sciences, Iran

P

arkinson's Disease (PD) is a progressive neurodegenerative movement disorder characterized by selective loss of

dopaminergic neurons and the presence of Lewy bodies. Treatment for PD that prevents neuronal death in the

dopaminergic system and abnormal protein deposition in the brain is not yet available. Evidence from human and animal

studies has suggested that oxidative damage critically contributes to neuronal loss in PD. This study aimed to evaluate the

potential neuroprotective effects of carvacrol on PC12 cells treated with 6-OHDA, a cellular model of Parkinson's disease.

Carvacrol, a naturally occurring monoterpenic phenol and food additive, has been shown to have antimicrobials, antitumor,

neuroprotective and antidepressant like activities. We found that carvacrol protect against 6-OHDA induced cell death in a

dose-dependent manner. Neuroprotection was found to coincide with increasing cell viability and reductions in intracellular

reactive oxygen species and lipid peroxidation. This study demonstrates that carvacrol protected against 6-OHDA induced

cell death via inhibition of oxidative stress, suggesting that carvacrol may be a candidate neuroprotective agent for 6-OHDA

induced Parkinsonism and possibly for other genetic or sporadic forms of PD.

Biography

Mahboubeh Manouchehrabadi is currently pursuing MSc in Developmental Biology from Islamic Azad University of Karaj, Iran. She is expert in experimenting

in

vitro

and

in vivo

models of Parkinson’s disease.

m.manouchehri.m@gmail.com

Mahboubeh Manouchehrabadi et al., J Neurol Neurosci 2017, 8:6

DOI: 10.21767/2171-6625-C1-006